biotechnology company
H.R.2810, Medicare Patient Access and Quality Improvement Act of 2013; Medicare reimbursement issues. Issues related to FY2015 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations and H.R.83, Consolidated and Further Continuing Appropriations Act, 2015. S.2260, EXPIRE Act of 2014; H.R.5771, Tax Increase Prevention Act of 2014; issues related to tax reform. Implementation issues related to the Pharmaceutical Quality, Security, and Accountability Act (P.L. 113-54); H.R.1416, Cancer Patient Protection Act of 2013; pharma supply chain issues; S.2007, Preventing Regulatory Overreach To Enhance Care Technology Act of 2014 (PROTECT Act); issues related to the 340B Program.
MMM - Medicare/Medicaid BUD - Budget/Appropriations TAX - Taxation/Internal Revenue Code HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
CROSSROADS STRATEGIES, LLC
800 North Capitol Street, NW, Suite 800, Washington, DC, 20002, US
TODD MATTHEW WEISS MATHEW LAPINSKI JOHN GREEN STEWART HALL HUNTER MOORHEAD MATT WISE STEVE TILTON ANNE BRADY JAKE PERRY TODD MATTHEW WEISS MATHEW LAPINSKI JOHN GREEN STEWART HALL HUNTER MOORHEAD MATT WISE STEVE TILTON ANNE BRADY JAKE PERRY TODD MATTHEW WEISS MATHEW LAPINSKI JOHN GREEN STEWART HALL HUNTER MOORHEAD MATT WISE STEVE TILTON ANNE BRADY JAKE PERRY TODD MATTHEW WEISS MATHEW LAPINSKI JOHN GREEN STEWART HALL HUNTER MOORHEAD MATT WISE STEVE TILTON ANNE BRADY JAKE PERRY